Iwatsuki-Horimoto K - Search Results

1

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

Horimoto T, Takada A, Fujii K, Goto H, Hatta M, Watanabe S, Iwatsuki-Horimoto K, Ito M, Tagawa-Sakai Y, Yamada S, Ito H, Ito T, Imai M, Itamura S, Odagiri T, Tashiro M, Lim W, Guan Y, Peiris M, Kawaoka Y. Horimoto T, et al. Vaccine. 2006 Apr 24;24(17):3669-76. doi: 10.1016/j.vaccine.2005.07.005. Epub 2005 Jul 21. Vaccine. 2006. PMID: 16378663

2

Identification of the porcine cytomegalovirus major capsid protein gene.

Rupasinghe V, Iwatsuki-Horimoto K, Sugii S, Horimoto T. Rupasinghe V, et al. J Vet Med Sci. 2001 Jun;63(6):609-18. doi: 10.1292/jvms.63.609. J Vet Med Sci. 2001. PMID: 11459006 Free article.

3

Capsid protein gene variation among feline calicivirus isolates.

Horimoto T, Takeda Y, Iwatsuki-Horimoto K, Sugii S, Tajima T. Horimoto T, et al. Virus Genes. 2001;23(2):171-4. doi: 10.1023/a:1011892120875. Virus Genes. 2001. PMID: 11724270

4

Generation of influenza A viruses with chimeric (type A/B) hemagglutinins.

Horimoto T, Takada A, Iwatsuki-Horimoto K, Hatta M, Goto H, Kawaoka Y. Horimoto T, et al. J Virol. 2003 Jul;77(14):8031-8. doi: 10.1128/jvi.77.14.8031-8038.2003. J Virol. 2003. PMID: 12829842 Free PMC article.

5

The index influenza A virus subtype H5N1 isolated from a human in 1997 differs in its receptor-binding properties from a virulent avian influenza virus.

Iwatsuki-Horimoto K, Kanazawa R, Sugii S, Kawaoka Y, Horimoto T. Iwatsuki-Horimoto K, et al. J Gen Virol. 2004 Apr;85(Pt 4):1001-1005. doi: 10.1099/vir.0.19519-0. J Gen Virol. 2004. PMID: 15039542

6

Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003.

Horimoto T, Fukuda N, Iwatsuki-Horimoto K, Guan Y, Lim W, Peiris M, Sugii S, Odagiri T, Tashiro M, Kawaoka Y. Horimoto T, et al. J Vet Med Sci. 2004 Mar;66(3):303-5. doi: 10.1292/jvms.66.303. J Vet Med Sci. 2004. PMID: 15107562

7

A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.

Horimoto T, Takada A, Iwatsuki-Horimoto K, Kawaoka Y. Horimoto T, et al. Vaccine. 2004 Jun 2;22(17-18):2244-7. doi: 10.1016/j.vaccine.2003.11.019. Vaccine. 2004. PMID: 15149783

8

Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components.

Horimoto T, Iwatsuki-Horimoto K, Hatta M, Kawaoka Y. Horimoto T, et al. Microbes Infect. 2004 May;6(6):579-83. doi: 10.1016/j.micinf.2004.02.011. Microbes Infect. 2004. PMID: 15158192 Free article.

9

Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence.

Iwatsuki-Horimoto K, Horimoto T, Fujii Y, Kawaoka Y. Iwatsuki-Horimoto K, et al. J Virol. 2004 Sep;78(18):10149-55. doi: 10.1128/JVI.78.18.10149-10155.2004. J Virol. 2004. PMID: 15331747 Free PMC article.

10

Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions.

Muramoto Y, Takada A, Fujii K, Noda T, Iwatsuki-Horimoto K, Watanabe S, Horimoto T, Kida H, Kawaoka Y. Muramoto Y, et al. J Virol. 2006 Mar;80(5):2318-25. doi: 10.1128/JVI.80.5.2318-2325.2006. J Virol. 2006. PMID: 16474138 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters